Professor
Johns Hopkins University
Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of at Johns Hopkins. Working with psychedelics since 2004, he has played a role in the modern-day revival of psychedelic research. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in about 50 years from the US government to administer a classic psychedelic as a treatment, specifically psilocybin for tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He has been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News, BBC, the Lex Fridman Podcast, the Huberman Lab Podcast, Big Think and Michael Pollan.
Disclosure(s): AJNA Labs: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Beckley Psychedelic Ltd: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Clarion Clinics: Consultant/Advisory Board (Ongoing); Negev Capital: Consultant/Advisory Board (Ongoing); Otsuka Pharmaceutical Development & Commercialization, Inc.: Consultant/Advisory Board (Ongoing); Reunion Neurosciences: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Friday, March 29, 2024
1:30 PM – 2:30 PM MDT